RVMD
USDRevolution Medicines Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$57.990
Haut
$59.680
Bas
$57.740
Volume
2.37M
Fondamentaux de l'Entreprise
Capitalisation Boursière
10.9B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
2.19M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
RBC Capital Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $77
RBC Capital analyst Leonid Timashev initiates coverage on Revolution Medicines with a Outperform rating and announces Price Target of $77.
Revolution Medicines' RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer
REDWOOD CITY, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today
Mizuho Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $90
Mizuho analyst Joseph Catanzaro initiates coverage on Revolution Medicines with a Outperform rating and announces Price Target of $90.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.